JP2024529425A5 - - Google Patents
Info
- Publication number
- JP2024529425A5 JP2024529425A5 JP2024504461A JP2024504461A JP2024529425A5 JP 2024529425 A5 JP2024529425 A5 JP 2024529425A5 JP 2024504461 A JP2024504461 A JP 2024504461A JP 2024504461 A JP2024504461 A JP 2024504461A JP 2024529425 A5 JP2024529425 A5 JP 2024529425A5
- Authority
- JP
- Japan
- Prior art keywords
- grna
- amino acid
- cas9
- adenosine deaminase
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163225322P | 2021-07-23 | 2021-07-23 | |
| US63/225,322 | 2021-07-23 | ||
| US202163255927P | 2021-10-14 | 2021-10-14 | |
| US63/255,927 | 2021-10-14 | ||
| PCT/US2022/074041 WO2023004409A1 (en) | 2021-07-23 | 2022-07-22 | Guide rnas for crispr/cas editing systems |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024529425A JP2024529425A (ja) | 2024-08-06 |
| JP2024529425A5 true JP2024529425A5 (enExample) | 2025-07-18 |
Family
ID=83149172
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024504461A Pending JP2024529425A (ja) | 2021-07-23 | 2022-07-22 | ＣＲＩＳＰＲ／Ｃａｓ編集系のためのガイドＲＮＡ |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240301405A1 (enExample) |
| EP (1) | EP4373931A1 (enExample) |
| JP (1) | JP2024529425A (enExample) |
| KR (1) | KR20240037299A (enExample) |
| AU (1) | AU2022313315A1 (enExample) |
| CA (1) | CA3226664A1 (enExample) |
| WO (1) | WO2023004409A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3198671A1 (en) * | 2020-10-14 | 2022-04-21 | Beam Therapeutics Inc. | Compositions and methods for treating glycogen storage disease type 1a |
| WO2024220980A2 (en) * | 2023-04-20 | 2024-10-24 | The Schepens Eye Research Institute, Inc. | Dscam inhibitory nucleic acids and methods of use thereof |
| AU2024270764A1 (en) | 2023-05-15 | 2025-12-04 | Nchroma Bio, Inc. | Compositions and methods for epigenetic regulation of hbv gene expression |
| WO2025087411A1 (zh) * | 2023-10-25 | 2025-05-01 | 尧唐(上海)生物科技有限公司 | 一种脱氨酶、包含其的碱基编辑器及其应用 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4880635B1 (en) | 1984-08-08 | 1996-07-02 | Liposome Company | Dehydrated liposomes |
| US4921757A (en) | 1985-04-26 | 1990-05-01 | Massachusetts Institute Of Technology | System for delayed and pulsed release of biologically active substances |
| US4920016A (en) | 1986-12-24 | 1990-04-24 | Linear Technology, Inc. | Liposomes with enhanced circulation time |
| JPH0825869B2 (ja) | 1987-02-09 | 1996-03-13 | 株式会社ビタミン研究所 | 抗腫瘍剤包埋リポソ−ム製剤 |
| US4917951A (en) | 1987-07-28 | 1990-04-17 | Micro-Pak, Inc. | Lipid vesicles formed of surfactants and steroids |
| US4911928A (en) | 1987-03-13 | 1990-03-27 | Micro-Pak, Inc. | Paucilamellar lipid vesicles |
| US5846946A (en) | 1996-06-14 | 1998-12-08 | Pasteur Merieux Serums Et Vaccins | Compositions and methods for administering Borrelia DNA |
| AU2005274948B2 (en) | 2004-07-16 | 2011-09-22 | Genvec, Inc. | Vaccines against aids comprising CMV/R-nucleic acid constructs |
| US8404658B2 (en) | 2007-12-31 | 2013-03-26 | Nanocor Therapeutics, Inc. | RNA interference for the treatment of heart failure |
| AU2013266968B2 (en) | 2012-05-25 | 2017-06-29 | Emmanuelle CHARPENTIER | Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription |
| CN105139759B (zh) | 2015-09-18 | 2017-10-10 | 京东方科技集团股份有限公司 | 一种拼接屏 |
| EP3356533A1 (en) * | 2015-09-28 | 2018-08-08 | North Carolina State University | Methods and compositions for sequence specific antimicrobials |
| IL310721B2 (en) | 2015-10-23 | 2025-11-01 | Harvard College | Nucleobase editors and uses thereof |
| CN110214183A (zh) | 2016-08-03 | 2019-09-06 | 哈佛大学的校长及成员们 | 腺苷核碱基编辑器及其用途 |
| JP7564087B2 (ja) * | 2018-07-30 | 2024-10-08 | サレプタ セラピューティクス， インコーポレイテッド | アンチセンス送達のための三量体ペプチド |
| JP2020038883A (ja) | 2018-09-03 | 2020-03-12 | 株式会社オートネットワーク技術研究所 | 回路構造体及び回路構造体の製造方法 |
| CA3154759A1 (en) * | 2019-09-23 | 2021-04-01 | Flagship Pioneering Innovations V, Inc. | Modulating genomic complexes |
| EP4058032A4 (en) * | 2019-12-19 | 2024-01-10 | Entrada Therapeutics, Inc. | Compositions for delivery of antisense compounds |
-
2022
- 2022-07-22 KR KR1020247005580A patent/KR20240037299A/ko active Pending
- 2022-07-22 AU AU2022313315A patent/AU2022313315A1/en active Pending
- 2022-07-22 EP EP22761858.4A patent/EP4373931A1/en active Pending
- 2022-07-22 CA CA3226664A patent/CA3226664A1/en active Pending
- 2022-07-22 WO PCT/US2022/074041 patent/WO2023004409A1/en not_active Ceased
- 2022-07-22 JP JP2024504461A patent/JP2024529425A/ja active Pending
-
2024
- 2024-01-22 US US18/418,751 patent/US20240301405A1/en active Pending